NETWORK META-ANALYSIS OF THE EFFICACY AND SAFETY OF SEVEN ORAL PHOSPHODIESTERASE 5 INHIBITORS FOR ERECTILE DYSFUNCTION

被引：0
|
作者：
Madeira, C. R. [1 ]
Leonart, L. [1 ]
Tonin, F. S. [1 ]
Fachi, M. M. [1 ]
Borba, H. H. [1 ]
Szpak, R. [1 ]
Fernandez-Llimos, F. [2 ]
Goncalves, A. G. [1 ]
Pontarolo, R. [1 ]
机构：
[1] Univ Fed Parana, Curitiba, Parana, Brazil
[2] Univ Lisbon, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIH59
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis
    Camilla R. Madeira
    Fernanda S. Tonin
    Mariana M. Fachi
    Helena H. Borba
    Vinicius L. Ferreira
    Leticia P. Leonart
    Aline F. Bonetti
    Rogerio P. Moritz
    Angela C. L. B. Trindade
    Alan G. Gonçalves
    Fernando Fernandez-Llimos
    Roberto Pontarolo
    [J]. World Journal of Urology, 2021, 39 : 953 - 962
  • [2] Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis
    Madeira, Camilla R.
    Tonin, Fernanda S.
    Fachi, Mariana M.
    Borba, Helena H.
    Ferreira, Vinicius L.
    Leonart, Leticia P.
    Bonetti, Aline F.
    Moritz, Rogerio P.
    Trindade, Angela C. L. B.
    Goncalves, Alan G.
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (03) : 953 - 962
  • [3] Comment on “Efficacy and safety of oral phosphodiesterase 5 inhibitor for erectile dysfunction: a network meta-analysis and multicriteria decision”
    Kumar Rajiv Ranjan
    Gopal Sharma
    [J]. World Journal of Urology, 2021, 39 : 2815 - 2816
  • [4] Comment on "Efficacy and safety of oral phosphodiesterase 5 inhibitor for erectile dysfunction: a network meta-analysis and multicriteria decision"
    Ranjan, Kumar Rajiv
    Sharma, Gopal
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (07) : 2815 - 2816
  • [5] Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
    Yuan, JinQiu
    Zhang, RenJie
    Yang, ZuYao
    Lee, Jack
    Liu, YaLi
    Tian, JinHui
    Qin, XiWen
    Ren, ZhengJia
    Ding, Hong
    Chen, Qing
    Mao, Chen
    Tang, JinLing
    [J]. EUROPEAN UROLOGY, 2013, 63 (05) : 902 - 912
  • [6] COMPARATIVE EFFICACY AND SAFETY OF PHOSPHODIESTERASE 5 INHIBITORS FOR ERECTILE DYSFUNCTION IN MEN WITH COMORBIDITIES: SYSTEMATIC REVIEW WITH NETWORK META-ANALYSIS
    Madeira, C. R.
    Leonart, L.
    Tonin, F. S.
    Ferreira, V. L.
    Bonetti, A. F.
    Pasquini-Netto, H.
    Fernandez-Llimos, F.
    Goncalves, A. G.
    Pontarolo, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S192 - S192
  • [7] Efficacy and Safety of Phosphodiesterase-5 Inhibitors for Treating Erectile Dysfunction in Kidney Transplant Recipients: A Meta-Analysis
    Lv Fanbin
    Mei, Yang
    Yan, Zhang
    Yang Yirong
    Zheng Shaoling
    Yong, Cai
    Peng, Xia
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (03) : 184 - 189
  • [8] Re: Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-Analysis Editorial Comment
    Seftel, Allen
    [J]. JOURNAL OF UROLOGY, 2013, 190 (04): : 1340 - 1340
  • [9] Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: A Trade-off Network Meta-analysis
    Chen, Liang
    Staubli, Sergej E. L.
    Schneider, Marc P.
    Kessels, Alfons G.
    Ivic, Sandra
    Bachmann, Lucas M.
    Kessler, Thomas M.
    [J]. EUROPEAN UROLOGY, 2015, 68 (04) : 674 - 680
  • [10] Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials
    Liao, Xinyang
    Qiu, Shi
    Bao, Yige
    Wang, Wanyu
    Yang, Lu
    Wei, Qiang
    [J]. WORLD JOURNAL OF UROLOGY, 2019, 37 (06) : 1061 - 1074
12345